Many adults with ADHD feel emotions quickly and strongly. Frustration flares fast, irritation is hard to shake, and moods can swing within a day. Researchers call this emotional dysregulation. It is common in ADHD and well studied, but it is not one of the formal diagnostic criteria.
"Rejection sensitive dysphoria", or RSD, is a newer and popular term. It describes intense emotional pain after real or perceived rejection or criticism. RSD is not a recognised diagnosis. The term came from one psychiatrist's clinical experience, and research on it is still at an early stage.
This page explains what each term means, what the evidence does and does not show, and what tends to help.
One review defines emotional dysregulation as difficulty changing an emotional state "in an adaptive and goal oriented way". It describes excitability, quick anger and mood lability (moods that shift easily). In plain terms: emotions arrive fast, feel big, and take a while to settle.
The research on adults points the same way:
A 2014 review in the American Journal of Psychiatry reached a similar view. It found emotional dysregulation is common in ADHD across the lifespan and "a major contributor to impairment".
Not officially, but it is closely linked.
The HSE's model of care for adult ADHD lists the DSM-5 diagnostic criteria. Emotional symptoms are listed separately, as "associated features" that support a diagnosis. These are "low frustration tolerance, irritability, mood lability". The HSE also notes that mood lability is characteristic of adult ADHD but sits outside the criteria.
Experts disagree on whether that should change. A 2019 practitioner review summed up the debate. Some researchers think emotional symptoms are a core feature of ADHD. Others argue they are too non-specific, because they also appear in many other conditions. The review found no agreed way yet to define them specifically for ADHD.
If you want the brain-science background, see what's actually different in an ADHD brain. For the signs clinicians look for overall, see signs of ADHD in adults.
A 2026 critical review explains that US psychiatrist William Dodson introduced the term. It was based on his clinical experience with people with ADHD. It then spread widely through social media among people with ADHD and autistic people.
RSD is not one of the DSM-5 criteria for ADHD. It is not among the associated features the HSE model of care lists either. No clinician can diagnose you with RSD as a condition in its own right.
That does not mean the experience is imagined. It means the label is informal, and no agreed way to measure it exists yet.
Psychologists already had a related, more established concept: "rejection sensitivity". It is usually treated as a personality disposition: a tendency to expect rejection, spot it readily and react strongly. It is also seen in depression, body dysmorphic disorder and borderline personality disorder.
The 2026 review argues clinicians should use this established term instead of RSD. It names four risks of the RSD label:
The same review also acknowledges that the term can offer "meaningful validation and connectedness".
The evidence is small and mixed. Most of it is in young people or students.
The Ginapp authors suggest RSD may be a learned response to repeated rejection, rather than a core feature of ADHD. They say more research is needed to find out how common it is. We found no reliable figure for how many adults with ADHD experience it.
Even without a formal label, the distress is real. Participants in the 2026 UK study described anxiety, misery and embarrassment. Some withdrew from others and became lonely. In the 2023 study, several people said learning the term helped them understand their reactions.
Emotional difficulties also seem to weigh heavily on daily life. The 2014 review called emotional dysregulation a major source of impairment in ADHD.
Strong or changeable emotions are not unique to ADHD. That is one reason they are not used to diagnose it. A clinician will think about other explanations, or conditions that sit alongside ADHD.
The HSE model of care includes a checklist from the UK Adult ADHD Network comparing the two:
Fear of abandonment can sound a lot like rejection sensitivity. That is why a careful assessment, not a label, is the way to sort this out.
Tell the assessor about your emotional patterns, not just attention problems. NICE says an adult ADHD assessment should include a full developmental and psychiatric history. The HSE model of care says mood lability is a common reason ADHD is missed when it is not considered.
A 2018 meta-analysis pooled 21 double-blind randomised trials in adults. ADHD medicines improved emotional dysregulation compared with placebo, with small-to-moderate effects:
The authors suggest these medicines may be less effective on the emotional side than on core ADHD symptoms.
Medication can also cause emotional side effects. UK product information for methylphenidate (Concerta XL) lists mood swings, irritability and affect lability among its common side effects. It also says aggression or hostility should be monitored. NICE says that if behaviour worsens, the prescriber should adjust medication and review the diagnosis. More on how these medicines work is in what ADHD stimulants actually do.
NICE recommends a structured psychological intervention focused on ADHD for adults who need non-drug treatment, which may include CBT. The HSE model of care describes treatment that targets core symptoms "and also mood lability", combining medication and psychological approaches.
We found no trials testing treatments for RSD specifically. In the 2023 focus groups, some people coped by reminding themselves not to take things personally in the moment. Others said strong social support helped.
The HSE model of care points adults with ADHD to ADHD Ireland for information and support.
If you are thinking about suicide or self-harm, get help now.
No. It is not a diagnosis in DSM-5 and not one of the associated features of ADHD listed by the HSE. The feelings people describe are real, but the label is informal. Research on it is limited and mostly qualitative.
It is a recognised associated feature, not a diagnostic criterion. Research shows it is much more common in adults with ADHD than in people without. Experts are still debating whether it should become a core symptom.
It can help a little for many people. A 2018 meta-analysis found small-to-moderate improvements in emotional dysregulation compared with placebo. Some people get mood swings or irritability as side effects. Talk to your prescriber about any change.
They can look alike and can occur together. Borderline personality disorder involves features such as frantic efforts to avoid abandonment, identity disturbance and chronic emptiness. A clinician, not a checklist, is the right person to tell them apart.
You can read about Proco's planned assessment service on our assessments page.
This article is general information, not medical advice. It cannot diagnose ADHD or any other condition. Talk to your GP or prescriber about your own situation, and never stop or change a medicine without their advice.
Reviewed by: Proco Team
Last updated: November 2026